
|Articles|July 1, 2002
PCa supplement found tainted, pulled from the market
Orlando, FL-Just as researchers were beginning to quantify the value of PC-SPES in treating advanced prostate cancer, the product was found to be contaminated, was taken off the market, and the manufacturer went out of business.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
2
Farah Rahman, MD, on monitoring resident wellness using biofeedback
3
Pearls & Perspectives: Innovation and Evolving Pathways in Female Pelvic Medicine, with Raveen Syan, MD, FPMRS
4
Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing
5






